UNSPSC 85641135: Supplement of chest subcutaneous tissue and fascia with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement of chest subcutaneous tissue and fascia with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JU60KZ

UNSPSC 85641135 Supplement of chest subcutaneous tissue and fascia with nonautologous tissue substitute, open approach (Commodity) shows minimal alignment with state and local procurement activity. The code describes a specific surgical procedure involving chest tissue augmentation, yet recent state and local contract opportunities tagged under this code do not center on the procedure itself but rather on medical evaluation, surveillance, and benefit administration services that fall outside the code's narrow clinical scope.

The six recent opportunities posted between July and September 2026 span disability medical evaluation services (City of Phoenix Retirement Office RFP due October 16, 2026), occupational medical surveillance for ferry workers (Washington State Department of Transportation due October 9, 2026), surgical benefit carve-out program management (City of Long Beach due October 7, 2026), emergency and specialty healthcare for detained youth (Harris County Juvenile Probation Department RFI due September 25, 2026), pharmacy benefit management administration (Collier County Board of County Commissioners due April 9, 2026), and temporary health professional staffing pool qualification (County of Santa Clara Health System due October 7, 2026). These solicitations represent administrative healthcare services, personnel staffing coordination, and benefit plan management—not surgical tissue supplements or implants. The mismatch suggests either miscoding at the source level or that this commodity code does not reflect active state and local procurement in the tissue augmentation space. No issuing body repeats across the recent record, and geographic activity spans Arizona, Washington, California, Florida, and Texas without concentrated regional focus. Firms pursuing tissue-supplement contracts should verify the accuracy of this code against specific opportunities before investing in proposal development, as the recent posting history does not support active market demand for the procedure the code nominally describes.